Cingulate Inc. (NASDAQ:CINGW) Short Interest Up 283.0% in July

Cingulate Inc. (NASDAQ:CINGW) was the recipient of a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 1,149 shares, a growth of 283.0% from the June 30th total of 300 shares. Based on an average daily volume of 6,798 shares, the short-interest ratio is currently 0.2 days.

Cingulate Stock Down 14.8%

NASDAQ CINGW traded down $0.00 on Friday, reaching $0.02. The stock had a trading volume of 12,287 shares, compared to its average volume of 34,847. The stock has a fifty day moving average price of $0.02 and a two-hundred day moving average price of $0.04. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.16.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.